公开(公告)号：US20210100864A1

公开(公告)日：2021-04-08

申请号：US17035690

申请日：2020-09-29

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Jungyeob HAM ,  Taejung KIM ,  Bong Chul CHUNG ,  Seok LEE ,  Bong Geun SONG ,  Sungdo HA ,  Young Tae PARK ,  Pilju CHOI ,  Hoon RYU

IPC: A61K36/185 ,  A61K31/05 ,  A23L33/105 ,  A61K8/34 ,  A61K8/9789 ,  B01J19/12

Abstract: Provided are: a method of preparing a cannabis processed product having an increased CBD content in an efficient and economic manner, through a decarboxylation reaction by continuous microwave irradiation of a cannabis extract; and use of a processed product having an increased CBD content prepared by the method, a fraction thereof, and a single ingredient of CBD, in foods, drugs, and cosmetics.

公开(公告)号：US20190242766A1

公开(公告)日：2019-08-08

申请号：US16199741

申请日：2018-11-26

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Sungwook YANG ,  Eui-Sung YOON ,  Hoon RYU ,  Hyeonjoo IM

IPC: G01L5/00 ,  A61B5/103

CPC classification number: G01L5/0052 ,  A61B5/1036 ,  A61B5/4064 ,  A61B2503/40 ,  A61B2562/0219

Abstract: A quantitative impact control and measurement system includes an impactor configured to apply an impact to a target, a control device configured to control movement of the impactor, an acceleration sensor mounted to a base of the impactor, and an impact sensor mounted to a terminal of the impactor. Here, the control device calculates an impact actually applied to the target from signals measured through the acceleration sensor and the impact sensor.

公开(公告)号：US20170354650A1

公开(公告)日：2017-12-14

申请号：US15403404

申请日：2017-01-11

Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Hyunah CHOO ,  Sun-Joon MIN ,  Yun Kyung KIM ,  Hoon RYU ,  Hyemyung SEO ,  Juhyeon KIM ,  Jihoon JANG ,  Sungsu LIM ,  Younghee KIM ,  Yu Jin HWANG ,  Yong Seo CHO

IPC: A61K31/47 ,  A61K31/4709 ,  A61K31/5377

CPC classification number: A61K31/47 ,  A61K31/4709 ,  A61K31/5377

Abstract: The present disclosure relates to a quinoline derivative which inhibits the activity of histone methyltransferases (ESET/SETDB1) specific for the histone molecule H3K9 or a pharmaceutically acceptable salt thereof and a use thereof.